Akkaya, OzgurKarahan, Oguz2026-01-242026-01-2420241995-18921680-0745https://doi.org/10.5830/CVJA-2023-013https://hdl.handle.net/20.500.12868/4933Background: In the current guidelines, dual antiplatelet therapy [acetylsalicylic acid (ASA) + clopidogrel] is recommended for at least three months after peripheral iliac stenting. In this study, we investigated the effect on clinical outcomes of adding ASA in different doses and at different times after Methods: Seventy-one patients were administered dual antiplatelet therapy after successful iliac stenting. Group 1, consisting of 40 patients, was given 75 mg of clopidogrel plus 75 mg of ASA in a single dose in the morning. In group 2, separate doses of 75 mg of clopidogrel (in the morning) and 81 mg of 1 x 1 ASA (in the evening) were started in 31 patients after the procedure were recorded. resulting in reduced haemoglobin levels (p = 0.038). dose of ASA.eninfo:eu-repo/semantics/closedAccessperipheral arterial revascularisationdual antiplatelet therapyacetylsalicylic acid dosingoutcomebleedingArticle10.5830/CVJA-2023-013352102105373588992-s2.0-85203957991Q3WOS:001015870500001Q4